Apollo Management Holdings’s MaxCyte MXCT Stock Holding History
Bought
Maintained
Sold
Other funds holding MXCT
CFM
VP
VCM
MA
BFM
Apollo Management Holdings's MXCT Position: Q1 2026 in Review
Apollo Management Holdings held its MaxCyte (MXCT) position steady in Q1 2026 at 307,987 shares worth $216K. The position accounts for ﹤0.01% of the portfolio, ranked #76.
Apollo Management Holdings first reported a position in MXCT in Q3 2021 and has held it in 19 quarters since. The position peaked at $2.97M in Q3 2021. 130 funds tracked by Wall St. Rank hold MXCT as of Q1 2026.
- Apollo Management Holdings held 307,987 shares of MaxCyte worth $216K as of Q1 2026.
- Apollo Management Holdings left its MaxCyte share count unchanged in Q1 2026.
- MaxCyte made up ﹤0.01% of Apollo Management Holdings's portfolio in Q1 2026, its #76 holding.
- Apollo Management Holdings first reported a position in MaxCyte in Q3 2021 and has held it in 19 quarters since.
- Apollo Management Holdings's MaxCyte position peaked at $2.97M in Q3 2021.
- 130 funds tracked by Wall St. Rank held MaxCyte as of Q1 2026.
Based on Apollo Management Holdings's 13F filing for Q1 2026, filed 15 May 2026.